Company intelligence / Profile preview

Financière Arbevel

Paris, Île-de-France, Francearbevel.com ↗

Ownership: Private
Development stage: Other

Overview

Financière Arbevel is a Paris-based investment management firm specializing in healthcare and life sciences investments. Through dedicated funds such as Pluvalca Health Opportunities and Aesculape SRI as well as the private equity "Arbevel Life Sciences Crossover II" fund, it provides capital to biotech/pharma/healthcare companies at various development stages across Europe. It is not itself a drug developer but supports innovation by investing in leading-edge therapeutic and diagnostic ventures.

Therapeutic areas: OncologyRare DiseasesOther
Modalities: Small moleculeBiologicAntibody-drug conjugateCell therapy
Industry: Investors

Partnerships

Portfolio partnerships with European biotech/pharma firms through investment rounds

Beyond the preview

Go deeper on Financière Arbevel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Financière Arbevel.

Explore the full profile